| Employment |
| Company: Dana-Farber Cancer Institute |
| Recipient: You |
|
| Leadership |
| Company: NCCN |
| Recipient: You |
|
| Stock and Other Ownership Interests |
| Company: tosk |
| Recipient: You |
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Merck |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: GSK |
| Recipient: You |
| Company: EMD Serono |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: Boehringer Ingelheim |
| Recipient: You |
| Company: ALX Oncology |
| Recipient: You |
| Company: aveo |
| Recipient: You |
| Company: Genmab |
| Recipient: You |
| Company: PDS Biotechnology |
| Recipient: You |
| Company: Scholar Rock |
| Recipient: You |
| Company: Genzyme |
| Recipient: You |
| Company: Johnson & Johnson/Janssen |
| Recipient: You |
| Company: RAPT Therapeutics |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Merck |
| Recipient: Your Institution |
| Company: Bristol-Myers Squibb |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Genentech |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Kura |
| Recipient: Your Institution |
| Company: EMD Serono |
| Recipient: Your Institution |
| Company: Incyte |
| Recipient: Your Institution |
| Company: Merus |
| Recipient: Your Institution |
| Company: AVEO |
| Recipient: Your Institution |
| Company: GlaxoSmithKline |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| Please describe: up to Date |
| Recipient: You |
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| Company: Nanobiotix |
| Recipient: You |
| Company: ISA Pharmaceuticals |
| Recipient: You |
| Company: Boehringer Ingelheim |
| Recipient: You |
| Company: Hookipa Pharma |
| Recipient: You |
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|